BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30500868)

  • 1. Semen Quality and Sperm DNA Integrity in Patients With Severe Active Inflammatory Bowel Disease and Effects of Tumour Necrosis Factor-alpha Inhibitors.
    Grosen A; Bungum M; Christensen LA; Cordelli E; Larsen OH; Leter G; Julsgaard M; Vestergaard T; Villani P; Hvas CL; Kelsen J
    J Crohns Colitis; 2019 Apr; 13(5):564-571. PubMed ID: 30500868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sperm DNA Integrity is Unaffected by Thiopurine Treatment in Men With Inflammatory Bowel Disease.
    Grosen A; Nersting J; Bungum M; Christensen LA; Schmiegelow K; Spanò M; Julsgaard M; Cordelli E; Leter G; Larsen PB; Hvas CL; Kelsen J
    J Crohns Colitis; 2019 Jan; 13(1):3-11. PubMed ID: 29917107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Concentration of Anti-TNF Antibodies, Adverse Effects and Quality of Life in Patients with Inflammatory Bowel Disease in Remission on Maintenance Treatment.
    Brandse JF; Vos LM; Jansen J; Schakel T; Ponsioen CI; van den Brink GR; D'Haens GR; Löwenberg M
    J Crohns Colitis; 2015 Nov; 9(11):973-81. PubMed ID: 26116557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays.
    Barclay ML; Karim S; Helms ETJ; Keating PE; Hock B; Stamp LK; Schultz M
    Intern Med J; 2019 Apr; 49(4):513-518. PubMed ID: 30091273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease.
    Billiet T; Dreesen E; Cleynen I; Wollants WJ; Ferrante M; Van Assche G; Gils A; Vermeire S
    Am J Gastroenterol; 2016 Oct; 111(10):1438-1445. PubMed ID: 27481307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.
    Peter I; Dubinsky M; Bressman S; Park A; Lu C; Chen N; Wang A
    JAMA Neurol; 2018 Aug; 75(8):939-946. PubMed ID: 29710331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of drug survival between infliximab and adalimumab in inflammatory bowel disease.
    Gil-Candel M; Gascón-Cánovas JJ; Urbieta-Sanz E; Rentero-Redondo L; Onteniente-Candela M; Iniesta-Navalón C
    Int J Clin Pharm; 2020 Apr; 42(2):500-507. PubMed ID: 32006141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose Methotrexate Therapy Does Not Affect Semen Parameters and Sperm DNA.
    Grosen A; Bellaguarda E; Nersting J; Hvas CL; Liljeqvist-Soltic I; Stein A; Christensen LA; Ruderman EM; Brown CR; Schmiegelow K; Zhang JX; Kelsen J; Hanauer SB
    Inflamm Bowel Dis; 2022 Jul; 28(7):1012-1018. PubMed ID: 34463329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of antioxidant treatment on DNA fragmentation index: a double-blind placebo-controlled randomized trial.
    Stenqvist A; Oleszczuk K; Leijonhufvud I; Giwercman A
    Andrology; 2018 Nov; 6(6):811-816. PubMed ID: 30298673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate Reduces DNA Integrity in Sperm From Men With Inflammatory Bowel Disease.
    Ley D; Jones J; Parrish J; Salih S; Caldera F; Tirado E; Leader B; Saha S
    Gastroenterology; 2018 Jun; 154(8):2064-2067.e3. PubMed ID: 29481778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of human sperm DNA fragmentation index (DFI) related factors: a report of 1010 subfertile men in China.
    Lu JC; Jing J; Chen L; Ge YF; Feng RX; Liang YJ; Yao B
    Reprod Biol Endocrinol; 2018 Mar; 16(1):23. PubMed ID: 29540184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab and semen quality in men with inflammatory bowel disease.
    Mahadevan U; Terdiman JP; Aron J; Jacobsohn S; Turek P
    Inflamm Bowel Dis; 2005 Apr; 11(4):395-9. PubMed ID: 15803031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of inflammatory bowel disease patients treated with TNF-α inhibitors: two-year follow-up.
    Lehtola E; Haapamäki J; Färkkilä MA
    Scand J Gastroenterol; 2016 Dec; 51(12):1476-1481. PubMed ID: 27686143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases.
    Ungar B; Levy I; Yavne Y; Yavzori M; Picard O; Fudim E; Loebstein R; Chowers Y; Eliakim R; Kopylov U; Ben-Horin S
    Clin Gastroenterol Hepatol; 2016 Apr; 14(4):550-557.e2. PubMed ID: 26538204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease.
    Koutroubakis IE; Ramos-Rivers C; Regueiro M; Koutroumpakis E; Click B; Schwartz M; Swoger J; Baidoo L; Hashash JG; Barrie A; Dunn MA; Binion DG
    Inflamm Bowel Dis; 2015 Jul; 21(7):1587-93. PubMed ID: 25933393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of anti-TNF use and associated treatment outcomes in inflammatory bowel disease patients: results from an analysis of Dutch health insurance claims data.
    Bots SJA; Hoekman DR; Benninga MA; Ponsioen CY; D'Haens GR; Löwenberg M
    Neth J Med; 2017 Dec; 75(10):432-442. PubMed ID: 29256410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.
    Salvador-Martín S; Raposo-Gutiérrez I; Navas-López VM; Gallego-Fernández C; Moreno-Álvarez A; Solar-Boga A; Muñoz-Codoceo R; Magallares L; Martínez-Ojinaga E; Fobelo MJ; Millán-Jiménez A; Rodriguez-Martinez A; Vayo CA; Sánchez C; Tolin M; Bossacoma F; Pujol-Muncunill G; González de Caldas R; Loverdos I; Blanca-García JA; Segarra O; Eizaguirre FJ; García-Romero R; Merino-Bohórquez V; Sanjurjo-Sáez M; López-Fernández LA
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-α inhibitors do not impair sperm quality in males with ankylosing spondylitis after short-term or long-term treatment.
    Micu MC; Micu R; Surd S; Gîrlovanu M; Bolboacă SD; Ostensen M
    Rheumatology (Oxford); 2014 Jul; 53(7):1250-5. PubMed ID: 24599921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.
    Altwegg R; Combes R; Laharie D; De Ledinghen V; Radenne S; Conti F; Chazouilleres O; Duvoux C; Dumortier J; Leroy V; Treton X; Durand F; Dharancy S; Nachury M; Goutorbe F; Lamblin G; Boivineau L; Peyrin-Biroulet L; Pageaux GP
    Dig Liver Dis; 2018 Jul; 50(7):668-674. PubMed ID: 29655972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease.
    Aardoom MA; Veereman G; de Ridder L
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.